超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

美國DARA BioSciences
DARA的是一家制藥公司發展，獲得早期發展前途的治療分子。然后加速通過概念證明人類在隨后的伙伴關系，出售或出牌，大型醫療和制藥公司的發展。這一戰略的有效實施，有可能大大降低成本和風險，在發展過程中的事件。


DARA is a pharmaceutical development company that acquires promising therapeutic molecules in early stage development. It then expedites development through proof-of-concept in humans for subsequent partnering, sale or out-licensing to large healthcare and pharmaceutical companies. The effective implementation of this strategy has the potential to greatly reduce costs and event risks in the development process.

To effectively manage the risks and returns of the Company, DARA utilizes a stringent due diligence process anchored by our knowledge of a drug or technology candidate's attributes that will most likely yield commercial success. The due diligence, development and commercial expertise resident at DARA help ensure that we identify the highest caliber candidates. Precise, targeted research is then conducted to form a solid basis for future marketing approval as well as medical and commercial success.